This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Cornell University, Columbia University. Active years: 2018-2022.
Company Filing History:
2 out of 2,948 
1 out of 2,549 
Years Active: 2018-2022
Title: Innovations by Inventor Stefan Worgall
Introduction
Stefan Worgall is a notable inventor based in New York, NY (US), recognized for his contributions to medical science, particularly in the field of neonatal care. He holds 2 patents that focus on innovative methods to improve lung health in premature infants.
Latest Patents
One of his latest patents addresses HIF-stabilization and prevention of hyperoxia-induced neonatal lung disease. This patent discloses a method that involves administering HIF stabilizing small molecule drugs to premature infants who rely on mechanical ventilation and/or supplemental oxygen. The aim is to counteract the harmful effects of hyperoxia on lung development. Research conducted in a mouse model supports the effectiveness of HIF stabilizers during high oxygen exposure, demonstrating protection for the lungs. These stabilizers can be administered through various routes, including aerosolized forms using a ventilator, intravenous, intraperitoneal, or subcutaneous injections. Another significant patent focuses on methods to decrease susceptibility to asthmatic bronchoconstriction. This involves increasing sphingolipid content in the airways and lungs of a mammalian subject, thereby reducing airway reactivity and susceptibility to asthmatic conditions.
Career Highlights
Stefan Worgall has had a distinguished career, contributing to significant advancements in medical research. He has worked with prestigious institutions such as Cornell University and Columbia University, where he has been involved in groundbreaking research and development.
Collaborations
Throughout his career, Worgall has collaborated with esteemed colleagues, including Randi B Silver and Tilla S Worgall. These collaborations have further enriched his research and innovations in the field.
Conclusion
Stefan Worgall's work exemplifies the impact of innovative thinking in medical science, particularly in improving the health outcomes of vulnerable populations such as premature infants. His patents reflect a commitment to advancing neonatal care through scientific research and collaboration.